Oppenheimer & Co. Inc. cut its position in Encompass Health Corp (AMEX:EHC) by 2.1% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 228,154 shares of the company’s stock after selling 5,000 shares during the period. Oppenheimer & Co. Inc. owned about 0.23% of Encompass Health worth $17,785,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also recently made changes to their positions in EHC. Voya Investment Management LLC lifted its holdings in shares of Encompass Health by 47.9% in the 2nd quarter. Voya Investment Management LLC now owns 1,614,030 shares of the company’s stock worth $109,302,000 after acquiring an additional 522,941 shares during the last quarter. Principal Financial Group Inc. purchased a new position in Encompass Health in the 1st quarter worth about $76,632,000. Wells Fargo & Company MN increased its stake in Encompass Health by 22.1% in the 2nd quarter. Wells Fargo & Company MN now owns 1,223,413 shares of the company’s stock worth $82,849,000 after buying an additional 221,589 shares during the period. Dimensional Fund Advisors LP increased its stake in Encompass Health by 1.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,166,519 shares of the company’s stock worth $78,998,000 after buying an additional 11,185 shares during the period. Finally, Allianz Asset Management GmbH purchased a new position in Encompass Health in the 1st quarter worth about $52,876,000. 93.18% of the stock is owned by hedge funds and other institutional investors.
EHC has been the topic of several recent analyst reports. Credit Suisse Group raised their price target on shares of Encompass Health from $66.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, July 26th. Piper Jaffray Companies raised shares of Encompass Health from a “neutral” rating to an “overweight” rating in a research report on Thursday, July 26th. Mizuho reiterated a “buy” rating and issued a $82.00 target price on shares of Encompass Health in a research note on Thursday, July 26th. Zacks Investment Research upgraded shares of Encompass Health from a “hold” rating to a “buy” rating and set a $84.00 target price for the company in a research note on Friday, July 27th. Finally, UBS Group began coverage on shares of Encompass Health in a research note on Thursday. They issued a “buy” rating and a $86.00 target price for the company. One research analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $72.09.
Encompass Health (AMEX:EHC) last issued its quarterly earnings results on Monday, October 29th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.79 by $0.12. The company had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Encompass Health’s revenue was up 8.8% on a year-over-year basis.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 15th. Stockholders of record on Wednesday, January 2nd will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 1.87%. The ex-dividend date of this dividend is Monday, December 31st.
COPYRIGHT VIOLATION NOTICE: “Oppenheimer & Co. Inc. Sells 5,000 Shares of Encompass Health Corp (EHC)” was originally reported by BBNS and is owned by of BBNS. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://baseballnewssource.com/2018/11/18/encompass-health-corp-ehc-shares-sold-by-oppenheimer-co-inc/2886598.html.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Further Reading: Short Selling Stocks and Day Traders
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.